Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This dehydration is often the root cause of the nausea and dizziness patients report
Contains: 4 x 0.5 mL Single-Dose Prefilled Syringes Push to open PACKAGE/LABEL PRINCIPAL DISPLAY PANEL 1.7 mg Manual Prefilled Syringe NDC 0169-1617-14 List 161714 wegovy 1.7 mg (semaglutide) injection 1.7 mg/0.5 mL Use Wegovy 1 time a week For subcutaneous use only Each prefilled syringe delivers 1.7 mg semaglutide Rx only Dispense the enclosed Medication Guide to each patient
Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
People looking for an effective solution for dark spots, dullness and loss of firmness
